Bioactive Indole Alkaloid from Aspergillus amoenus TJ507 That Ameliorates Hepatic Ischemia/Reperfusion Injury

Yeting Zhang,Xiangli Zhao,Yunfang Cao,Ming Chen,Zhengyi Shi,Meng Wu,Hao Feng,Lingjuan Sun,Zhibo Ma,Xiaosheng Tan,Gang Chen,Changxing Qi,Yonghui Zhang
DOI: https://doi.org/10.1021/acs.jnatprod.3c00251
IF: 5.1
2023-08-10
Journal of Natural Products
Abstract:Hepatic ischemia/reperfusion injury (IRI) is a major factor contributing to the failure of hepatic resection and liver transplantation. As part of our ongoing investigation into bioactive compounds derived from fungi, we isolated eight indole alkaloids (<b>1</b>-<b>8</b>) from the endophytic fungus <i>Aspergillus amoenus</i> TJ507. Among these alkaloids, one previously undescribed compound, amoenamide D (<b>1</b>), was identified. The planar structure of <b>1</b> was elucidated by extensive spectroscopic analysis, including HRESIMS and NMR spectra. The absolute configuration of <b>1</b> was elucidated by using electronic circular dichroism calculations. Notably, in the CoCl<sub>2</sub>-induced hepatocyte damage model, notoamide Q (<b>3</b>) exhibited significant anti-hypoxia injury activity. Furthermore, in a murine hepatic ischemia/reperfusion injury model, treatment with <b>3</b> prevents IRI-induced liver damage and hepatocellular apoptosis. Consequently, <b>3</b> might serve as a potential lead compound to prevent hepatic ischemia/reperfusion injury.
plant sciences,chemistry, medicinal,pharmacology & pharmacy
What problem does this paper attempt to address?